Document Classification

Section Type: RESULTS

Text: In addition, colesevelam significantly (1) lowered fasting plasma glucose (-13. 9 mg/dL P =. 01), fructosamine (-23. 2 micromol/L ; P <. 001), total cholesterol (TC) (-7. 2 % ; P <. 001), low-density lipoprotein cholesterol (LDL-C) (-15. 9 % ; P <. 001), apolipoprotein B (-7. 9 % ; P <. 001), non-high-density lipoprotein cholesterol (HDL-C) (-10. 3 % ; P <. 001), and high-sensitivity C-reactive protein (-14. 4 % ; P =. 02) levels and (2) improved other measures of glycemic response, as well as TC/HDL-C, LDL-C/HDL-C, non-HDL-C/HDL-C, and apolipoprotein B/apolipoprotein A-I ratios (P <. 003 for all).